Conversational AI facilitates mental health assessments and is associated with improved recovery rates
Key Takeaways
Limbic Access improves recovery rates for mental illnesses in clinical setting
Limbic Access offers a more cost-effective solution to improving recovery rates compared to alternative methods
Background
In a world where mental health services face overwhelming demand and a shortage of qualified practitioners, digital solutions are emerging as a promising avenue to improve efficiencies and quality of care. This study explores the real-world impact of Limbic Access within clinical settings, with a specific focus on its impact on patient wellbeing measured through recovery from mild-to-moderate mental illness.
Methods
Conducted over a 14-month period, the study focused on recovery rates of 58,475 patients in 18 services employing Limbic Access. To ensure the validity of results, recovery rates in these services were compared to those in services without Limbic Access during the same time frame. Rigorous control analyses were implemented to account for potential confounding factors. In addition, an economic analysis compared the cost-effectiveness of Limbic Access for improving recovery against other methods.
Results
The study found that the use of Limbic Access is associated with improved recovery rates in the context of England’s NHS Talking Therapies services. This represents the first real-world evidence for the efficacy of AI solutions to improve the quality of mental health care. Services that used Limbic Access saw an improvement in patient reliable recovery rates from 47.1% to 48.9% compared to services without AI-enabled solutions, which saw a decrease in reliable recovery rates from 48.3% to 46.9% in the same time period.
In addition, an economic analysis revealed that the use of Limbic Access is more cost-effective than alternative solutions. Limbic Access exhibited an estimated cost per additional recovery ranging from £118.25 to £221.89, whereas alternative methods in the same study incurred costs up to 1014% higher at £1,200 per recovery in economic terms within two years.
90% lower cost per recovery
Than additional therapy sessions
Conclusions
In summary, these results indicate that the usage of AI-enabled referral tools, such as Limbic Access creates clinical efficacy and improves treatment outcomes for patients. Moreover, the economic analysis reveals that Limbic Access represents a cost-effective way of achieving these improvements, further suggesting a large potential for the adoption of this technology.
